Both IL-4 and IL-13 inhibit the TNF-α and IFN-γ enhanced MDC production in a human keratinocyte cell line, HaCaT cells
- 1 April 2003
- journal article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 31 (2) , 111-117
- https://doi.org/10.1016/s0923-1811(02)00149-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- IL-4, BUT NOT IL-13, MODULATES TARC (THYMUS AND ACTIVATION-REGULATED CHEMOKINE)/CCL17 AND IP-10 (INTERFERON-INDUCED PROTEIN OF 10 kDa)/CXCL10 RELEASE BY TNF-α AND IFN-γ IN HaCaT CELL LINECytokine, 2002
- Interferon-Gamma-Induced RANTES Production by Human Keratinocytes Is Enhanced by IL-1β, TNF-α, IL-4 and IL-13 and Is Inhibited by Dexamethasone and TacrolimusDermatology, 2001
- Expression of CC chemokine receptor 3 on human keratinocytes in vivo and in vitro — upregulation by RANTESJournal of Dermatological Science, 2001
- Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activityJournal of Allergy and Clinical Immunology, 2001
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3– and CC chemokine receptor 4–independent mannerJournal of Allergy and Clinical Immunology, 1999
- Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q131Cytogenetic and Genome Research, 1998
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993
- Keratinocytes as initiators of inflammationThe Lancet, 1991
- The Role of Epidermal Cytokines in Inflammatory Skin DiseasesJournal of Investigative Dermatology, 1990